GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » Market Cap

Lyka Labs (BOM:500259) Market Cap : ₹3,913 Mil (As of Apr. 18, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lyka Labs's share price for the quarter that ended in Dec. 2024 was ₹157.95. Lyka Labs's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 36 Mil. Therefore, Lyka Labs's market cap for the quarter that ended in Dec. 2024 was ₹5,637 Mil.

Lyka Labs's quarterly market cap increased from Jun. 2024 (₹3,851 Mil) to Sep. 2024 (₹5,180 Mil) and increased from Sep. 2024 (₹5,180 Mil) to Dec. 2024 (₹5,637 Mil).

Lyka Labs's annual market cap declined from Mar. 2022 (₹3,890 Mil) to Mar. 2023 (₹3,213 Mil) but then increased from Mar. 2023 (₹3,213 Mil) to Mar. 2024 (₹3,506 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lyka Labs's Enterprise Value for Today is ₹4,196 Mil.


Lyka Labs Market Cap Historical Data

The historical data trend for Lyka Labs's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Market Cap Chart

Lyka Labs Annual Data
Trend Jun14 Jun15 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 365.80 711.51 3,890.36 3,213.24 3,505.89

Lyka Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,119.71 3,505.89 3,850.95 5,180.40 5,637.24

Competitive Comparison of Lyka Labs's Market Cap

For the Biotechnology subindustry, Lyka Labs's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lyka Labs's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Market Cap distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Market Cap falls into.


;
;

Lyka Labs Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Lyka Labs's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹105.95*33.090
=₹3,506

Lyka Labs's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=₹157.95*35.690
=₹5,637

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lyka Labs  (BOM:500259) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Lyka Labs Market Cap Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Lyka Labs Business Description

Traded in Other Exchanges
Address
30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs Headlines

No Headlines